CAR-T therapies Archives - Express Pharma

Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies: GlobalData

New CAR-T therapies in South Korea to face stringent regulatory oversight: GlobalData

Kite gets US FDA nod for Yescarta to treat relapsed or refractory follicular lymphoma

Regenerative medicine market to reach $16.4 bn in 2026: GlobalData